Pfizer | PFE

Stock Price
28.60
Daily Change
-0.42 -1.45%
Monthly
12.64%
Yearly
-21.60%
Q2 Forecast
28.56
Peers Price Chg Day Year Date
AbbVie 166.20 1.60 0.97% 15.87% May/17
Abbott 103.99 -0.99 -0.94% -4.13% May/17
ALKERMES 24.15 -0.31 -1.27% -19.98% May/17
Amgen 312.47 -2.60 -0.83% 39.35% May/17
AstraZeneca 12,110.00 -56.00 -0.46% 1.10% May/17
Bayer 28.58 -0.07 -0.24% -47.18% May/17
Biogen 230.60 0.27 0.12% -24.50% May/17
Bristol-Myers Squibb 44.03 -0.15 -0.34% -32.98% May/17
Catalent 55.36 0.09 0.16% 72.24% May/17
Gilead Sciences 67.71 -0.20 -0.29% -13.43% May/17
GlaxoSmithKline 1,775.00 -8.50 -0.48% 24.67% May/17
Glaxosmithkline 44.98 0.10 0.22% 27.75% May/17
J&J 154.59 0.38 0.25% -2.45% May/17
Eli Lilly 769.90 -2.53 -0.33% 75.82% May/17
Medtronic 85.93 0.20 0.23% -3.47% May/17
Merck 131.20 -0.07 -0.05% 15.09% May/17
Neurocrine Biosciences 142.29 0.38 0.27% 49.98% May/17
Novartis 93.37 0.75 0.81% 3.16% May/17
Novartis 102.58 -0.11 -0.10% 2.22% May/17
Prestige Brands 64.65 -0.33 -0.51% 8.46% May/17
Pacira 30.82 -0.69 -2.19% -23.50% May/17
Pfizer 28.60 -0.42 -1.45% -21.60% May/17
Perrigo 29.86 -0.27 -0.88% -10.69% May/17
Drreddys Laboratories 68.26 -1.04 -1.50% 27.97% May/17
Regeneron Pharmaceuticals 982.29 13.64 1.41% 31.41% May/17
Roche Holding 237.10 2.30 0.98% -17.75% May/17
Sanofi 89.17 -1.07 -1.19% -10.71% May/17
Sanofi 48.64 -0.22 -0.45% -9.69% May/17
Vertex Pharmaceuticals 445.23 4.35 0.99% 31.16% May/17
Zoetis 173.97 -0.18 -0.10% -3.20% May/17

Indexes Price Day Year Date
US500 5303 6.17 0.12% 26.33% May/17

Pfizer traded at $28.60 this Friday May 17th, decreasing $0.42 or 1.45 percent since the previous trading session. Looking back, over the last four weeks, Pfizer lost 12.64 percent. Over the last 12 months, its price fell by 21.60 percent. Looking ahead, we forecast Pfizer to be priced at 28.56 by the end of this quarter and at 27.74 in one year, according to Trading Economics global macro models projections and analysts expectations.

Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products. Its global portfolio includes medicines and vaccines. The Company works across markets to develop wellness, prevention, treatments and cures. It collaborates with healthcare providers, governments and local communities to support and provide access to healthcare. Its medicines and vaccines provide value for healthcare providers and patients, through treatment of diseases, improvements in health, wellness. It sells its prescription pharmaceutical products to wholesalers, retailers, hospitals, clinics, government agencies and pharmacies. In the United States, it sells its vaccines products to the federal government, centers for disease control and prevention (CDC), wholesalers, individual provider offices, retail pharmacies and integrated delivery networks.